A practical reference on 反相色谱: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-23. Anything still debated is marked as such rather than presented as settled.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nm is the standard purity method, reported as area percent. Mass spectrometry, usually with electrospray ionisation, confirms identity and reveals covalent modifications. Size-exclusion chromatography quantifies aggregates and fragments. Peptide mapping after enzymatic digestion localises changes to specific sequence regions. Circular dichroism and infrared spectroscopy report on secondary structure, while light scattering tracks particle formation in liquid formulations. No single technique captures every quality attribute.
Quality control for peptide material focuses on identity, purity, content and the profile of impurities. Common degradants include deamidated and oxidised forms, plus aggregates formed during storage or handling. Forced degradation studies under heat, light, acid and peroxide help define which conditions accelerate change and which analytical methods detect it. Limits for individual impurities are set by pharmacopoeial monographs or manufacturer specifications. How much a given impurity affects biological activity is often uncertain, and conclusions may depend on the assay used.
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilised powder | visual inspection of solid |
| Solubility | Freely soluble in water, pH dependent | buffer choice affects clarity |
| Typical storage | -20 °C, desiccated, protected from light | solution form kept at 2-8 °C |
| Primary purity method | RP-HPLC with UV detection, 214-220 nm | reported as area percent |
| Identity confirmation | LC-ESI-MS, approximately 4114 Da | compared with theoretical mass |
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
=== Pregnancy and breastfeeding === Currently, melarsoprol is not recommended for use in pregnant women. The World Health Organization suggests that treatment be deferred until immediately after delivery since the effects of the medication on the developing fetus have not yet been established. Lactation guidelines associated with melarsoprol have not yet been established.
"APS user shares the "Israeli Nobel" for chemistry", from the Argonne National Laboratory Advanced Photon Source (APS), United States Department of Energy The Official Site of Louisa Gross Horwitz Prize Weizmann Institute of Science, Yonath-Site Talk by Ada Yonath at the Origins 2011 congress Ada E. Yonath on Nobelprize.org Ada Yonath at IMDb
Afferent nerves conduct sensory information from sensory neurons to the central nervous system, for example from the mechanoreceptors in skin. Bundles of afferent fibers are known as sensory nerves. Efferent nerves conduct signals from the central nervous system along motor neurons to their target muscles and glands. Bundles of these fibres are known as efferent nerves. Mixed nerves contain both afferent and efferent axons, and thus conduct both incoming sensory information and outgoing muscle commands in the same bundle. All spinal nerves are mixed nerves, and some of the cranial nerves are also mixed nerves. Nerves can be categorized into two groups based on where they connect to the central nervous system:
Unlike the Push mode, players can capture any area regardless of which team controls the other areas. On some maps, players are awarded with points for every 30 seconds they control an area while on other maps, teams are rewarded with reinforcements every 30 seconds when every single area is controlled by that team. OBJ (Objective) – The last type of objective is a collective of objectives that do not fall under the other four types, or is a combination of different types of objectives. On most obj maps, players have to plant bombs in order to destroy certain map areas. The bombs can be defused within 30 seconds by the opposing team to prevent this.
Dictionaries commonly record that the word tea is used to refer to other plants beside the tea plant and to beverages made from these other plants. The term herbal tea is well established and more common than tisane for this usage. Furthermore, in the Etymology of tea, the most ancient term for tea was 荼 (pronounced tu) which originally referred to various plants such as sow thistle, chicory, or smartweed, and was later used to exclusively refer to Camellia sinensis (true "tea"). The word tisane was rare in its modern sense before the 20th century, when it was borrowed in the modern sense from French. This is why some people feel it should be pronounced as in French, but the original English pronunciation continues to be more common in US English and especially in UK English. The word had already existed in late Middle English in the sense of "medicinal drink" and had already been borrowed from French (Old French). The Old French word came from the Latin word ptisana, which came from the Ancient Greek word πτισάνη (ptisánē), which meant "peeled" barley, in other words pearl barley, and a drink made from this that is similar to modern barley water.
Sources: en.wikipedia.org
== Additional application == Acetoacetyl-CoA also behaves as a product of acetoacetyl-CoA synthetase (AACS) within the cytosol, using acetoacetate as the substrate, the reaction provides acetyl groups for lipogenesis. Understanding acetoacetyl-CoA is important in cholesterol development and lipogenesis and Acetoacetyl-CoA synthetase playing a role in its development, it also plays a significant role within the brain. Cholesterol and fats have been observed in high concentrations within neuronal tissue, as well as high AACS mRNA expression levels within cells of the hippocampus and cortical region. In addition, they play a significant role in neuronal development during the early embryonic and fetal developmental stages.
1993/2046) Police (Amendment) (No.3) Regulations 1993 (S.I. 1993/2047) Goods Vehicles (Plating and Testing) (Amendment) Regulations 1993 (S.I. 1993/2048) National Health Service (Travelling Expenses and Remission of Charges) (Scotland) Amendment (No.2) Regulations 1993 (S.I. 1993/2049) Prisoners and Criminal Proceedings (Scotland) Act 1993 Commencement, Transitional Provisions and Savings Order 1993 (S.I. 1993/2050) A34 Trunk Road (A34/M4 Junction 13 Improvement) Line and Slip Roads Order 1993 (S.I. 1993/2056) A6 Trunk Road (Great Glen Bypass) Order 1993 (S.I. 1993/2057) A6 Trunk Road (Great Glen Bypass) (Detrunking) Order 1993 (S.I. 1993/2058) Easington Lagoons (Area of Special Protection) (No.2) Order 1993 (S.I. 1993/2059) Capacity Serving Measures (Intoxicating Liquor) (Amendment) Regulations 1993 (S.I. 1993/2060) Enforcement of Road Traffic Debts (Certificated Bailiffs) Regulations 1993 (S.I. 1993/2072) Enforcement of Road Traffic Debts Order 1993 (S.I. 1993/2073) Education (School Performance Information) (England) (No. 2) Regulations 1993 (S.I. 1993/2077) Housing Renovation etc. Grants (Prescribed Forms and Particulars) (Welsh Forms and Particulars) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/2078) Lerwick Harbour Revision Order 1993 (S.I. 1993/2087) Safety of Sports Grounds (Designation) Order 1993 (S.I. 1993/2090) Essex and Greater London (County Boundaries) Order 1993 (S.I. 1993/2091) Social Security (Contributions) Amendment (No. 6) Regulations 1993 (S.I. 1993/2094) Local Authorities (Goods and Services) (Public Bodies) Order 1993 (S.I.
== Mechanism == Bile is secreted by the liver to aid in the digestion of fats. Bile formation begins in bile canaliculi that form between two adjacent surfaces of liver cells (hepatocytes) similar to the terminal branches of a tree. The canaliculi join each other to form larger and larger structures, sometimes referred to as the canals of Hering, which themselves join to form small bile ductules that have an epithelial surface. The ductules join to form bile ducts that eventually form either the right main hepatic duct that drains the right lobe of the liver, or the left main hepatic duct draining the left lobe of the liver. The two ducts join to form the common hepatic duct, which in turn joins the cystic duct from the gall bladder, to give the common bile duct. This duct then enters the duodenum at the ampulla of Vater. In cholestasis, bile accumulates in the hepatic parenchyma. One of the most common causes of extrahepatic, or obstructive cholestasis, is biliary obstruction. This is better known as choledocholithiasis where gallstones become stuck in the common bile duct.
=== Bab–Bar === Stephen Moulton Babcock (1843–1931), American agricultural chemist worked on the "single-grain experiment" Myrtle Bachelder (1908–1997), American chemist noted for work on the Manhattan Project atomic bomb, and for work on metal chemistry Werner Emmanuel Bachmann (1901–1951), American chemist, known for work in steroids and RDX Simone Badal-McCreath (21st century), Jamaican chemist who created prostate and breast cancer cell lines Leo Baekeland (1863–1944), Belgian-American chemist known for invention of bakelite Adolf von Baeyer (1835–1917), German chemist, 1905 Nobel Prize in Chemistry, synthesis of indigo Piero Baglioni (born 1952), Italian chemist known for inorganic and organic colloids Hendrik Willem Bakhuis Roozeboom (1854–1907), Dutch chemist who studied phase behaviour in physical chemistry Alice Ball (1892–1916), American chemist known for inventing an effective injectable treatment for leprosy Emily Balskus (born 1980), American chemist and microbiologist known for work on the human microbiome Zhenan Bao (born 1970), Chinese chemist known for developing technologies with organic field-effect transistors and organic semiconductors Phil S. Baran (born 1977), American chemist known for synthesis, novel reactions and reagents Coral Barbas (PhD 1989), Spanish chemist known for research on metabolomics and integration of chemical data Allen J.
Sources: en.wikipedia.org
=== Mid-infrared === With the advent of cheap microcomputers it became possible to have a computer dedicated to controlling the spectrometer, collecting the data, doing the Fourier transform and presenting the spectrum. This provided the impetus for the development of FTIR spectrometers for the rock-salt region. The problems of manufacturing ultra-high precision optical and mechanical components had to be solved. A wide range of instruments are now available commercially. Although instrument design has become more sophisticated, the basic principles remain the same. Nowadays, the moving mirror of the interferometer moves at a constant velocity, and sampling of the interferogram is triggered by finding zero-crossings in the fringes of a secondary interferometer lit by a helium–neon laser. In modern FTIR systems the constant mirror velocity is not strictly required, as long as the laser fringes and the original interferogram are recorded simultaneously with higher sampling rate and then re-interpolated on a constant grid, as pioneered by James W. Brault. This confers very high wavenumber accuracy on the resulting infrared spectrum and avoids wavenumber calibration errors.
Regular production batches of 238PuO2 particles precipitated as a hydroxide were used to show that large production batches could be effectively 16O2-exchanged on a routine basis. High-fired 238PuO2 microspheres were successfully 16O2-exchanged showing that an exchange will take place regardless of the previous heat treatment history of the 238PuO2. This lowering of the neutron emission rate of PuO2 containing normal oxygen by a factor of five was discovered during the cardiac pacemaker research at Mound Laboratory in 1966, due in part to the Mound Laboratory's experience with production of stable isotopes beginning in 1960. For production of the large heat sources the shielding required would have been prohibitive without this process. Unlike the other three isotopes discussed in this section, 238Pu must be specifically synthesized and is not abundant as a nuclear waste product. At present only Russia has maintained high-volume production, while in the US, no more than 50 g (1.8 oz) were produced in total between 2013 and 2018. The US agencies involved desire to begin the production of the material at a rate of 300 to 400 grams (11 to 14 oz) per year. If this plan is funded, the goal would be to set up automation and scale-up processes in order to produce an average of 1.5 kg (3.3 lb) per year by 2025.
7 CH2=CH2 + 6 O2 → 6 (CH2CH2)O + 2 CO2 + 2 H2O and the maximum degree of conversion of ethylene to ethylene oxide is theoretically predicted to be 6/7 or 85.7%, although higher yields are achieved in practice. The catalyst for the reaction is metallic silver deposited on various matrixes, including pumice, silica gel, various silicates and aluminosilicates, alumina, and silicon carbide, and activated by certain additives (antimony, bismuth, barium peroxide, etc.). The process temperature was optimized as 220–280 °C (430–540 °F). Lower temperatures reduce the activity of the catalyst, and higher temperatures promote the complete oxidation of ethylene thereby reducing the yield of ethylene oxide. Elevated pressure of 1–3 MPa (150–440 psi) increases the productivity of the catalyst and facilitates absorption of ethylene oxide from the reacting gases. Whereas oxidation by air is still being used, oxygen (> 95% purity) is preferred for several reasons, such as higher molar yield of ethylene oxide (75–82% for oxygen vs. 63–75% for air), higher reaction rate (no gas dilution) and no need of separating nitrogen in the reaction products.
=== Future technology and research === Gene therapy is being explored as a treatment for missense mutations. This involves inserting the correct sequence of DNA into an incorrect gene. Artificial Intelligence programs, such as AlphaFold, are also being developed to predict the effect of missense mutations. Identifying potential deleterious mutations can assist with disease diagnosis and treatment.
== Organisations == Opus Group Berhad, a consortium of several different companies operating under the Opus brand name Opus Energy, an electricity and gas supplier based in the UK Opus College of Business, US
Sources: en.wikipedia.org
Reverse-phase high-performance liquid chromatography with ultraviolet detection is the usual choice, with results reported as area percent. Complementary methods such as size-exclusion chromatography and mass spectrometry are needed because a single separation cannot resolve every impurity class. Purity figures are therefore method dependent and should always be read alongside the technique used.
Oxidation mainly affects methionine residues and is promoted by dissolved oxygen, trace transition metals, and prolonged exposure to light. Buffer choice and the presence of antioxidants in a formulation can alter the rate appreciably. Because the products differ in mass by only a few units, mass spectrometry is often required to detect them.
Published data on long-term ambient stability are limited, so the question remains open rather than settled. Short excursions during transport are common in practice, and many suppliers use insulated packaging with cold packs. Where stability data are absent, cold-chain handling with temperature logging is the safer approach.
Lower temperatures slow hydrolysis, oxidation and aggregation reactions that degrade the molecule over time. Lyophilised powder is more tolerant than solution, but both benefit from controlled conditions.